Enanta Pharmaceuticals
NASDAQ: ENTA1 known investors
Enanta Pharmaceuticals is a biotechnology company that discovers and develops small-molecule therapeutics using chemistry-based research to treat diseases with high unmet medical need. Its work has contributed to hepatitis C virus combination therapies, and its pipeline includes programs in areas such as respiratory syncytial virus (RSV).
Investors Β· 1
Funding
SEC filings, press & company announcements- Undisclosed amountpublic offeringOct 2025Source β
Source: company announcements and press reports β follow each round's link for the claim.
In the news
Frequently asked questions
- What does Enanta Pharmaceuticals do?
- Enanta Pharmaceuticals is a biotechnology company that discovers and develops small-molecule therapeutics using chemistry-based research to treat diseases with high unmet medical need. Its work has contributed to hepatitis C virus combination therapies, and its pipeline includes programs in areas such as respiratory syncytial virus (RSV).
- Who are Enanta Pharmaceuticals's investors?
- Enanta Pharmaceuticals's investors include Sofinnova Ventures.